Global Brain And Neuroimaging Devices Price 2025, Forecast To 2034
24 Mar, 2025
What Has Been The Evolution of the Brain And Neuroimaging Devices Market in Recent Years?
The brain and neuroimaging devices market has seen considerable growth due to a variety of factors.
• The market size for brain and neuroimaging devices has seen robust growth in recent years. There is an expected increase from $40.65 billion in 2024 to $43.03 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.8%.
Factors contributing to the growth during the historic period include diagnosis and treatment of neurological disorders, the aging population, research on brain mapping and connectivity, as well as expansion in emerging markets.
What Are the Future Growth Projections for the Brain And Neuroimaging Devices Market?
The brain and neuroimaging devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market for brain and neuroimaging devices is predicted to witness significant expansion in the subsequent years, hitting a valuation of $54.73 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%.
Factors contributing to this growth in the projected period encompass regulatory backing, customizable treatments, specialized therapies, and value-driven healthcare. The forecast period is also expected to be characterized by trends like high-definition imaging, multimodal imaging, wearable neuroimaging, plus connectivity and functional imaging.
Which Key Drivers Are Propelling The Brain And Neuroimaging Devices Market's Growth?
The rising occurrence of neurological disorders could potentially catalyze the market. A report from the European Academy of Neurology shows that in 2022, neurological diseases will impact one in every three individuals and that there has been a nearly 40% spike in deaths related to these disorders over the previous three decades. Intended for diagnosing these neurological conditions, brain and neuroimaging devices improve the chances of survival and disease management. This heightened prevalence rate is predicted to stimulate the market for brain and neuroimaging devices.
What Are The Major Segments Within The Global Brain And Neuroimaging Devices Market?
The brain and neuroimaging devices market covered in this report is segmented –
1) By Imaging Type: Functional Magnetic Resonance Imaging (FMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magneto Encephalography (MEG), Other Imaging Types
2) By Application: Parkinson’s Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders, Other Applications
3) By End-User: Hospitals, Diagnostic Centres, Ambulatory Surgical Centres
Subsegments:
1) By Functional Magnetic Resonance Imaging (FMRI): Resting-State FMRI, Task-Based FMRI, Diffusion Tensor Imaging (DTI) With FMRI
2) By Computed Tomography (CT): X-ray CT, Positron Emission Tomography (PET) Or CT Hybrid Imaging, Multi-Slice CT
3) By Positron Emission Tomography (PET): PET Or CT, PET Or MRI
4) By Electroencephalography (EEG): Conventional EEG, Ambulatory EEG, High-Density EEG
5) By Magnetoencephalography (MEG): Whole-Head MEG, Electromagnetic Source Imaging (ESI) With MEG
6) By Other Imaging Types: Near-Infrared Spectroscopy (NIRS), Transcranial Magnetic Stimulation (TMS), Optical Coherence Tomography (OCT)
Which Trends Are Expected To Transform The Brain And Neuroimaging Devices Market?
Organizations and scientists are concentrating on creating portable brain scanners that aim to bring a revolution in brain imaging by reducing the device costs, thereby making them inexpensive and readily available to everyone. EMVision Medical Devices in collaboration with researchers at Queensland University have innovated a portable brain scanner technology capable of conducting brain scans in nearly any location. Similarly, researchers at University College London have fashioned a portable MEG brain scanner that is light in weight and can be worn like a helmet, capturing brain activity during natural movements. This offers enhanced imaging options for patients suffering from disorders that lead to spontaneous bodily movements, for instance, epilepsy.
Who Are the Key Players In The Brain And Neuroimaging Devices Market?
Major companies operating in the brain and neuroimaging devices market include:
• GE HealthCare
• Siemens AG
• Koninklijke Philips
• Canon Medical Systems Corporation
• Hitachi Medical Systems
• Medtronic Plc.
• EB Neuro S.p.A.
• Neurosoft
• MinFound Medical Systems Co. Ltd.
• Elekta
• Varian Medical Systems
• Toshiba Corporation
• Shimadzu Corporation
• Agilent Technologies Inc.
• Waters Corporation
• Bruker Corporation
• PerkinElmer Inc.
• Luminex Corporation
• Bio-Rad Laboratories Inc.
• Carl Zeiss Meditec AG
• Fujifilm Holdings Corporation
• Hologic Inc.
• Nihon Kohden Corporation
• Natus Medical Incorporated
• RIMED Ltd.
• Advanced Brain Monitoring Inc.
• Intranerve Neuroscience Holdings LLC.
• Nuvasive Inc.
• SpecialtyCare Inc.
What Is The Most Dominant Region In The Brain And Neuroimaging Devices Market?
Western Europe was the largest region in the brain and neuroimaging devices market in 2023. North America was the second-largest region in the global brain and neuroimaging devices market report. Africa. was the smallest region in the brain and neuroimaging devices market. The regions covered in the brain and neuroimaging devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.